BR102019014802A2 - difluorometil-fenil triazóis - Google Patents

difluorometil-fenil triazóis Download PDF

Info

Publication number
BR102019014802A2
BR102019014802A2 BR102019014802A BR102019014802A BR102019014802A2 BR 102019014802 A2 BR102019014802 A2 BR 102019014802A2 BR 102019014802 A BR102019014802 A BR 102019014802A BR 102019014802 A BR102019014802 A BR 102019014802A BR 102019014802 A2 BR102019014802 A2 BR 102019014802A2
Authority
BR
Brazil
Prior art keywords
alkyl
group
pain
petition
disorders
Prior art date
Application number
BR102019014802A
Other languages
English (en)
Portuguese (pt)
Inventor
Perera Alexandre
Binder Florian
Montel Florian
Schreiber Larsen Janus
Ostermeier Markus
Hucke Oliver
Lipinski Radoslaw
Peters Stefan
Cui Yunhai
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BR102019014802A2 publication Critical patent/BR102019014802A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR102019014802A 2018-07-20 2019-07-18 difluorometil-fenil triazóis BR102019014802A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18184716 2018-07-20

Publications (1)

Publication Number Publication Date
BR102019014802A2 true BR102019014802A2 (pt) 2020-02-04

Family

ID=63014393

Family Applications (1)

Application Number Title Priority Date Filing Date
BR102019014802A BR102019014802A2 (pt) 2018-07-20 2019-07-18 difluorometil-fenil triazóis

Country Status (8)

Country Link
US (2) US10941137B2 (cg-RX-API-DMAC7.html)
EP (1) EP3823967B1 (cg-RX-API-DMAC7.html)
JP (1) JP7311583B2 (cg-RX-API-DMAC7.html)
CN (1) CN112424197B (cg-RX-API-DMAC7.html)
AR (1) AR117615A1 (cg-RX-API-DMAC7.html)
BR (1) BR102019014802A2 (cg-RX-API-DMAC7.html)
TW (1) TW202019915A (cg-RX-API-DMAC7.html)
WO (1) WO2020016443A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12649738B2 (en) 2020-03-26 2026-06-09 Richter Gedeon Nyrt. 1,3-dihydro-2H-pyrrolo[3,4-c]pyridine derivatives as GABAA α5 receptor modulators
TWI901650B (zh) * 2020-03-26 2025-10-21 匈牙利商羅特格登公司 啶及吡啶并〔3,4-c〕嗒衍生物
EP4149933B1 (en) * 2020-05-13 2024-06-12 F. Hoffmann-La Roche AG New triazolyl derivatives as gaba a alpha5 pam
EP3971179A1 (en) * 2020-09-22 2022-03-23 Boehringer Ingelheim International GmbH Difluoromethyl-pyridin-2-yl triazoles
TWI915398B (zh) * 2020-08-05 2026-02-21 丹麥商薩尼奧納有限責任公司 二氟甲基-吡啶-2-基三唑
EP3992188A1 (en) * 2020-10-29 2022-05-04 Boehringer Ingelheim International GmbH Difluoromethyl-pyridin-2-yl triazoles
EP3950683A1 (en) * 2020-08-05 2022-02-09 Boehringer Ingelheim International GmbH Difluoromethyl-pyridin-2-yl triazoles
IL310708A (en) * 2021-08-12 2024-04-01 Shanghai Simr Biotechnology Co Ltd The history of converted triazole, a method for its preparation, its pharmaceutical preparation and its use
HU231691B1 (hu) 2021-09-29 2025-10-28 Richter Gedeon Nyrt GABAA ALFA5 receptor modulátor hatású biciklusos aminszármazékok
CN116462664B (zh) * 2022-03-08 2025-07-01 上海赛默罗生物科技有限公司 吡唑环类化合物、其制备方法、组合物及应用
CN116854680A (zh) * 2022-03-28 2023-10-10 上海赛默罗生物科技有限公司 异噁唑-杂环类衍生物、药物组合物和用途
WO2024251133A1 (zh) * 2023-06-05 2024-12-12 武汉人福创新药物研发中心有限公司 作为α5-GABAA受体调节剂的杂环化合物及其用途

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009508905A (ja) 2005-09-19 2009-03-05 エフ.ホフマン−ラ ロシュ アーゲー GABAAα5逆アゴニストとしてのイソオキサゾロ誘導体
CN101277952B (zh) 2005-10-11 2011-09-28 弗·哈夫曼-拉罗切有限公司 异*唑衍生物
DE602006014185D1 (de) 2005-11-09 2010-06-17 Hoffmann La Roche 3-arylisoxazol-4-carbonylbenzofuranderivative
RU2426731C2 (ru) 2005-12-23 2011-08-20 Ф. Хоффманн-Ля Рош Аг Производные арил-изоксазоло-4-ил-оксадиазола
PL1968973T3 (pl) 2005-12-27 2012-03-30 Hoffmann La Roche Pochodne aryloizoksazol-4-iloimidazolu
ATE537171T1 (de) 2005-12-27 2011-12-15 Hoffmann La Roche Aryl-isoxazol-4-yl-imidazoä1,5-aüpyridin-deriva e
ES2340221T3 (es) 2006-05-24 2010-05-31 Eli Lilly And Company Compuestos y procedimientos para modular fxr.
KR101119365B1 (ko) 2006-05-31 2012-03-07 에프. 호프만-라 로슈 아게 아릴-4-에틴일-아이속사졸 유도체
EP1894928A1 (en) 2006-08-29 2008-03-05 PheneX Pharmaceuticals AG Heterocyclic fxr binding compounds
EP1894924A1 (en) 2006-08-29 2008-03-05 Phenex Pharmaceuticals AG Heterocyclic FXR binding compounds
CN101965344B (zh) 2007-06-22 2013-03-06 弗·哈夫曼-拉罗切有限公司 异*唑-咪唑衍生物
US7943619B2 (en) 2007-12-04 2011-05-17 Hoffmann-La Roche Inc. Isoxazolo-pyridazine derivatives
US7618973B2 (en) 2007-12-04 2009-11-17 Hoffmann-La Roche Inc. Isoxazolo-pyrazine derivatives
JP5301557B2 (ja) 2007-12-04 2013-09-25 エフ.ホフマン−ラ ロシュ アーゲー イソオキサゾロ−ピリジン誘導体
EP2128158A1 (en) 2008-05-26 2009-12-02 Phenex Pharmaceuticals AG Heterocyclic cyclopropyl-substituted FXR binding compounds
US8389550B2 (en) 2009-02-25 2013-03-05 Hoffmann-La Roche Inc. Isoxazoles / O-pyridines with ethyl and ethenyl linker
US8222246B2 (en) 2009-04-02 2012-07-17 Hoffmann-La Roche Inc. Substituted isoxazoles
US8227461B2 (en) 2009-04-30 2012-07-24 Hoffmann-La Roche Inc. Isoxazoles
BRPI1013762A2 (pt) 2009-05-05 2015-08-25 Hoffmann La Roche "derivados isoxazol-piridazina"
BRPI1014454A2 (pt) 2009-05-05 2016-04-05 Hoffmann La Roche derivados de isoxazol-pirazol
US8415379B2 (en) 2009-05-05 2013-04-09 Hoffmann-La Roche Inc. Pyridines
ES2601181T3 (es) 2009-05-05 2017-02-14 F. Hoffmann-La Roche Ag Derivados de isoxazol-tiazol como agonistas inversos del receptor GABA A para su uso en el tratamiento de trastornos cognitivos
KR101354416B1 (ko) 2009-05-07 2014-02-19 에프. 호프만-라 로슈 아게 감마-아미노부티르산 조절제로서 이속사졸-피리딘 유도체
EP2289883A1 (en) 2009-08-19 2011-03-02 Phenex Pharmaceuticals AG Novel FXR (NR1H4) binding and activity modulating compounds
CN103189062B (zh) 2010-11-05 2016-03-23 霍夫曼-拉罗奇有限公司 活性药物化合物用于治疗中枢神经系统病症的用途
US8742097B2 (en) * 2010-11-09 2014-06-03 Hoffmann-La Roche Inc. Triazole compounds I
RU2582337C2 (ru) * 2010-11-09 2016-04-27 Ф.Хоффманн-Ля Рош Аг Производные триазола в качестве лигандов рецепторов гамк
JP2014122161A (ja) 2011-03-31 2014-07-03 Astellas Pharma Inc ピラゾール化合物
WO2014001278A1 (en) * 2012-06-26 2014-01-03 Aniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
MX357504B (es) 2012-06-26 2018-07-12 Saniona Aps Derivado de feniltriazol y su uso para modular complejo del receptor gabaa.
EP2885290B1 (en) 2012-06-26 2017-10-18 Saniona A/S A phenyl triazole derivative and its use for modulating the gabaa receptor complex
WO2014001280A1 (en) * 2012-06-26 2014-01-03 Aniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
MA48594B1 (fr) 2016-12-08 2022-05-31 Hoffmann La Roche Nouveaux dérivés d'éther d'isoxazolyle en tant que pam alpha5 gaba a

Also Published As

Publication number Publication date
CN112424197A (zh) 2021-02-26
EP3823967A1 (en) 2021-05-26
TW202019915A (zh) 2020-06-01
JP2021531291A (ja) 2021-11-18
US20200024261A1 (en) 2020-01-23
US20210147393A1 (en) 2021-05-20
WO2020016443A1 (en) 2020-01-23
AR117615A1 (es) 2021-08-18
CN112424197B (zh) 2025-04-22
US10941137B2 (en) 2021-03-09
JP7311583B2 (ja) 2023-07-19
EP3823967B1 (en) 2022-08-31

Similar Documents

Publication Publication Date Title
EP3823967B1 (en) Difluoromethyl-phenyl triazoles as gaba receptor modulators
CA2927917C (en) Heteroaromatic compounds useful for the treatment of proliferative diseases
EP3033335B1 (en) Pyridinones
AU2014337067A1 (en) Heteroaromatic compounds useful for the treatment of proliferative diseases
CN106458990A (zh) 细胞周期蛋白依赖性激酶7(cdk7)的抑制剂
TW201217380A (en) New aminopyrazoloquinazolines
US20120295845A1 (en) Imidazo-pyrazoles as gpr119 inhibitors
ES3061465T3 (en) Difluoromethyl-pyridin-2-yl triazoles
EP2480551A1 (en) Gpr 119 modulators
IL325136A (en) Pyrazolo-pyrimidinone compounds for use in methods for inhibiting kinase week1 a
US10421750B2 (en) Substituted morpholine derivatives having activity against pain
EP4416148A2 (en) Carboline compounds and use thereof
US20190002475A1 (en) Oxa-diazaspiro compounds having activity against pain
HK40129488A (en) Difluoromethyl-pyridin-2-yl triazoles
CN120004864A (zh) 双环化合物,包含其的组合物及其应用
EP3971179A1 (en) Difluoromethyl-pyridin-2-yl triazoles
EP3950683A1 (en) Difluoromethyl-pyridin-2-yl triazoles
EP3992188A1 (en) Difluoromethyl-pyridin-2-yl triazoles

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements